| Document Date: 2015-02-04 15:25:00
Open Document File Size: 42,09 KBShare Result on Facebook
City Washington DC / / Company ACS / / Country Germany / United States / Canada / / Event Product Issues / / Facility The Institute of Medicine / / IndustryTerm chemical scientists / less hazardous technology base / low-level chemical exposure / pharmaceuticals / anthropogenic chemicals / target chemicals / measurement devices / chemical exposures / chemicals / chemical enterprise / chemical processes / environmental chemicals / oil spills / / MedicalCondition Chronic Disease / cumulative and chronic health impacts / / Organization American Chemical Society / Congress / National Research Council / Institute of Medicine / U.S. Centers for Disease Control and Prevention / / / Position analytical chemist / / Product substances / / ProgrammingLanguage DC / / URL www.acs.org/policy / /
SocialTag |
Public Policy StatementBIOMONITORING Biomonitoring involves the measurement of chemicals in humans (and other species) and is rapidly advancing our ability to detect and quantify potentially hazardous exposure